Status:
COMPLETED
Automation of Gamete Preparation, Intracytoplasmic Sperm Injection (ICSI), Embryo Culture, and Vitrification
Lead Sponsor:
Conceivable Life Sciences
Conditions:
Infertility
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Patients suffering from infertility may seek assisted conception treatment. In a full treatment cycle, the sperm and eggs (gametes) from the intended parents will be looked after by skilled laboratory...
Eligibility Criteria
Inclusion
- Medical indication to perform ICSI.
- Informed consent signed by the patients before treatment.
- Medical indication for the use of autologous or donor oocytes.
- Medical indication for the use of autologous or donor sperm.
- Motile sperm.
Exclusion
- Recurrent pregnancy loss.
- Previous history of total fertilization failure.
- Surgical sperm retrieval.
- Severe male factor infertility.
- Known semen liquefaction problems.
- Any other case abnormalities that could potentially reduce success rates according to the criteria of the senior embryologist in charge.
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 4 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06074835
Start Date
October 30 2023
End Date
October 4 2025
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hope Fertility Centre, Guadalajara
Guadalajara, Jalisco, Mexico, 44630